Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas van Groen

Showing results (21-30 of 87) with videos related to

Pageof 9
Sort By:
Journal of Neuroinflammation|November 16, 2005
A refined in vitro model to study inflammatory responses in organotypic membrane culture of postnatal rat hippocampal slicesJari Huuskonen, Tiina Suuronen, Riitta Miettinen, et al.
Experimental Neurology|November 14, 2002
Fimbria-fornix lesion does not affect APP levels and amyloid deposition in the hippocampus of APP+PS1 double transgenic miceLi Liu, Sami Ikonen, Tero Tapiola, et al.
Neurobiology of Disease|October 16, 2012
Neurodevelopmental impairment following neonatal hyperoxia in the mouseManimaran Ramani, Thomas van Groen, Inga Kadish, et al.
Plos One|April 9, 2013
Hunger in the absence of caloric restriction improves cognition and attenuates Alzheimer's disease pathology in a mouse modelEmily J Dhurandhar, David B Allison, Thomas van Groen, et al.
Advances in Protein Chemistry and Structural Biology|July 21, 2012
Treatment with Aβ42 binding D-amino acid peptides reduce amyloid deposition and inflammation in APP/PS1 double transgenic miceThomas van Groen, Inga Kadish, Aileen Funke, et al.
Brain Research|July 9, 2002
Alteration of cortical EEG in mice carrying mutated human APP transgeneJun Wang, Sami Ikonen, Kestutis Gurevicius, et al.
Neurobiology of Disease|December 2, 2004
Longitudinal observation on CSF Abeta42 levels in young to middle-aged amyloid precursor protein/presenilin-1 doubly transgenic miceLi Liu, Sanna-Kaisa Herukka, Rimante Minkeviciene, et al.
Chemmedchem|December 17, 2008
In vitro and in vivo staining characteristics of small, fluorescent, Abeta42-binding D-enantiomeric peptides in transgenic AD mouse modelsThomas van Groen, Inga Kadish, Katja Wiesehan, et al.
Stroke|June 4, 2005
Transformation of diffuse beta-amyloid precursor protein and beta-amyloid deposits to plaques in the thalamus after transient occlusion of the middle cerebral artery in ratsThomas van Groen, Kirsi Puurunen, Hanna-Mari Mäki, et al.
Journal of Alzheimer'S Disease : JAD|December 29, 2012
Treatment with D3 removes amyloid deposits, reduces inflammation, and improves cognition in aged AβPP/PS1 double transgenic miceThomas van Groen, Inga Kadish, Susanne Aileen Funke, et al.
Pageof 9

Showing results (21-30 of 87) with videos related to

Sort By:
Pageof 9
Journal of Neuroinflammation|November 16, 2005
A refined in vitro model to study inflammatory responses in organotypic membrane culture of postnatal rat hippocampal slicesJari Huuskonen, Tiina Suuronen, Riitta Miettinen, et al.
Experimental Neurology|November 14, 2002
Fimbria-fornix lesion does not affect APP levels and amyloid deposition in the hippocampus of APP+PS1 double transgenic miceLi Liu, Sami Ikonen, Tero Tapiola, et al.
Neurobiology of Disease|October 16, 2012
Neurodevelopmental impairment following neonatal hyperoxia in the mouseManimaran Ramani, Thomas van Groen, Inga Kadish, et al.
Plos One|April 9, 2013
Hunger in the absence of caloric restriction improves cognition and attenuates Alzheimer's disease pathology in a mouse modelEmily J Dhurandhar, David B Allison, Thomas van Groen, et al.
Advances in Protein Chemistry and Structural Biology|July 21, 2012
Treatment with Aβ42 binding D-amino acid peptides reduce amyloid deposition and inflammation in APP/PS1 double transgenic miceThomas van Groen, Inga Kadish, Aileen Funke, et al.
Brain Research|July 9, 2002
Alteration of cortical EEG in mice carrying mutated human APP transgeneJun Wang, Sami Ikonen, Kestutis Gurevicius, et al.
Neurobiology of Disease|December 2, 2004
Longitudinal observation on CSF Abeta42 levels in young to middle-aged amyloid precursor protein/presenilin-1 doubly transgenic miceLi Liu, Sanna-Kaisa Herukka, Rimante Minkeviciene, et al.
Chemmedchem|December 17, 2008
In vitro and in vivo staining characteristics of small, fluorescent, Abeta42-binding D-enantiomeric peptides in transgenic AD mouse modelsThomas van Groen, Inga Kadish, Katja Wiesehan, et al.
Stroke|June 4, 2005
Transformation of diffuse beta-amyloid precursor protein and beta-amyloid deposits to plaques in the thalamus after transient occlusion of the middle cerebral artery in ratsThomas van Groen, Kirsi Puurunen, Hanna-Mari Mäki, et al.
Journal of Alzheimer'S Disease : JAD|December 29, 2012
Treatment with D3 removes amyloid deposits, reduces inflammation, and improves cognition in aged AβPP/PS1 double transgenic miceThomas van Groen, Inga Kadish, Susanne Aileen Funke, et al.
Pageof 9